generic drug product quality assessment - fda generic drug forum 2018
Published 6 years ago • 304 plays • Length 20:15Download video MP4
Download video MP3
Similar videos
-
20:09
generic drug product quality assessment- fda generic drug forum 2018
-
20:14
generic drug product quality assessment (22of27) generic drugs forum 2018
-
16:50
microbiology quality assessment- fda generic drug forum 2018
-
16:51
microbiology quality assessment- fda generic drug forum 2018
-
20:18
drug substance quality assessment: best practices (23of27) generic drugs forum 2018
-
17:14
microbiology quality assessment (18of27) generic drugs forum 2018
-
1:26:21
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access-day 2, pt 2
-
7:12:31
advancing generic drug development: translating science to approval 2024 (day 1)
-
7:01:55
advancing generic drug development: translating science to approval 2024 (day 2)
-
12:35
integrated quality assessment process (19of27) generic drugs forum 2018
-
18:47
challenges in generic drug safety and surveillance (6of27) generic drugs forum 2018
-
18:34
challenges in generic drug safety and surveillance - fda generic drugs forum 2018
-
19:40
laboratory science to support risk based quality assessments- fda generic drug forum 2018
-
20:47
generic drug product quality review (23/28) generic drugs forum 2017
-
17:27
opq integrated quality assessment (iqa) process (20/28) generic drugs forum 2017
-
16:56
orange book: 101 an overview (11of27) generic drugs forum 2018
-
33:06
keynote address by dr. uhl (1of27) generic drugs forum 2018
-
17:27
pre-anda review: office of pharmaceutical quality (opq) (4of39) complex generics 2018
-
37:25
generic drug labeling: recommendations for high-quality submissions (4of28) generic drugs forum 2020
-
21:09
keynote from the office of pharmaceutical quality (opq) (2of16) generic drugs forum 2020
-
20:50
facility evaluation and inspection (26/28) generic drugs forum 2017
-
1:40:14
generic drugs forum (gdf) 2023: celebrating 10 years of the gdf – day 2 – session 3